Introduction: Carriers of the BRCA 1 and/or BRCA 2 mutation incur a lifetime risk of up to 85% for breast cancer and between 20 and 40% for ovarian cancer. Efforts to elucidate the lifetime risk of developing colorectal cancer with BRCA carrier mutations have demonstrated conflicting results. Consequently, there are no formal guidelines regarding the necessity for bowel screening for individuals with BRCA 1 and/or BRCA 2 mutations.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with B.
Contact B., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack